Awards & Advancement

Schulman IRB’s Central Oncology Review Division adds Judith Carrithers

Tuesday, October 4, 2016

Schulman IRB, a central IRB in customer service and technology, announced that Judith Carrithers, JD, MPA, will join its Central Oncology Review (COR) division October 15, 2016, as director of Oncology Services. Launching later in 2016, COR will provide collaborative, flexible IRB review services for oncology research centers seeking a more advanced level of partnership and service integration from a central IRB. [Read More]

CRF Health appoints Jamie Moss chief operating officer

Wednesday, September 28, 2016

CRF Health, a global provider of eCOA solutions for the life sciences industry, announced the appointment of Jamie Moss as chief operating officer (COO), assuming responsibility for CRF Health’s global operations. The company has enjoyed significant growth and continued investment in the eCOA space having recently acquired mHealth provider, Entra Health. This appointment continues to place an emphasis on ensuring quality and scalable operational delivery to meet growing customer demand.

[Read More]

2016 Lasker Awards honor scientists for basic and clinical medical research

Monday, September 26, 2016

The Albert and Mary Lasker Foundation has announced the winners of the 2016 Lasker Awards for medical science: William G. Kaelin, Peter J. Ratcliffe, and Gregg L. Semenza for basic medical research;Ralf F.W. Bartenschlager, Charles M. Rice, and Michael J. Sofia for clinical research; and Bruce M. Alberts for special achievement. The 2016 Lasker Awards, which carry an honorarium of $250,000 for each category, will be presented on Friday, September 23, in New York City.

[Read More]

Emma Walmsley to succeed Andrew Witty as CEO of GlaxoSmithKline

Wednesday, September 21, 2016

GSK has announced that Emma Walmsley, currently chief executive officer (CEO) of GSK’s Consumer Healthcare division, has been appointed GSK CEO Designate and will succeed Andrew Witty as GSK CEO when he retires on March 31, 2017. Walmsley will join the GSK board of directors January 2017.

[Read More]

Pediatric Cancer Foundation to honor Congressmen McCaul & Van Hollen

Wednesday, September 21, 2016

Congressman Michael Mccaul and Congressman Chris Van Hollen to be honored at the 3rd Annual Golden Toast. The Golden Toast represents bipartisan politics at its finest. It is an evening when members of Congress from both sides of the aisle demonstrate a commitment to some of the most vulnerable members of society—children who are fighting cancer. In an election season marked by divisiveness, the Golden Toast is a visible reminder that our elected officials can put aside disagreements to accomplish meaningful change and advance life-saving research. 

[Read More]

EMD Serono appoints Craig Millian SVP, Neurology And Immunology

Tuesday, September 20, 2016

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada, has announced the appointment of Craig Millian as senior vice president, Neurology and Immunology. Millian most recently served as senior vice president, head of U.S. Fertility and Endocrinology at EMD Serono. In his new role, he will lead the strategic direction of the company’s U.S. Neurology and Immunology franchise.

[Read More]